Stock Events

Stock Events

Celldex Therapeutics (TCE2.STU) Q2 2026 Earnings

7MayConfirmed

Q1 2026

Q2 2026

-1.03

-0.98

-0.92

-0.87

Details

Expected EPS

-0.98070181118

Actual EPS

-1.0061506

Surprise EPS

-0.03

Surprise Percent

+2.59%

Description

Celldex Therapeutics (TCE2.STU) has reported earnings of -1.0061506 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.